Posted by linkadge on June 21, 2020, at 17:22:45
In reply to Re: Can someone explain this COVID/MAO-B study?, posted by undopaminergic on June 20, 2020, at 5:53:55
>What about rasagiline? It could be the (l-) >amphetamine metabolites of selegiline.
This could play a role. However, there is more to MAO-B inhibition than simply elevation of PEA / dopamine. I don't pretend to understand it all myself, but there is a (perhaps bidirectional) interaction between MAO-B and inflammation / neuroprotective factors. MAO-B inhibitors likely don't prevent one from contracting COVID (again, not sure), but *may* reduce some of the deleterious neurological effects (again, just speculation at this point).
Linkadge
poster:linkadge
thread:1110832
URL: http://www.dr-bob.org/babble/20200511/msgs/1110918.html